Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Cash and Equivalents of $216.89 million for fiscal year 2025.
MARAVAI LIFESCIENCES HOLDINGS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $216.89M | -32.7% |
| 2024 | $322.40M | -44.2% |
| 2024 | $578.16M | +0.9% |
| 2024 | $573.17M | -0.3% |
| 2023 | $574.96M | -9.0% |
| 2022 | $632.14M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $243.57M | -57.9% | -9.8% |
| June 30, 2025 | $269.91M | -52.9% | -5.3% |
| March 31, 2025 | $285.05M | -49.3% | -11.6% |
| December 31, 2024 | $322.40M | -43.9% | -44.2% |
| September 30, 2024 | $578.16M | -0.2% | +0.9% |
| June 30, 2024 | $573.17M | -1.2% | +2.0% |
| March 31, 2024 | $561.69M | — | -2.3% |
| December 31, 2023 | $574.96M | -9.0% | -0.8% |
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -32.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, MARAVAI LIFESCIENCES HOLDINGS, INC.’s cash and equivalents has declined by 65.7% (from $632.14 million to $216.89 million).
- The most recent figure is from MARAVAI LIFESCIENCES HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: